Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a 18.038\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a.) CCC(CC)c1nnc(NC(=O)C2CCN(C(=O)c3ccco3)CC2)s1
b.) O=C(NCC1CCCO1)c1cn(Cc2ccccc2)nc1-c1ccccc1
c.) CCCCn1c(N)c(N(CC)C(=O)C2CCC2)c(=O)[nH]c1=O
Answer: a. CCC(CC)c1nnc(NC(=O)C2CCN(C(=O)c3ccco3)CC2)s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(CC)c1nnc(NC(=O)C2CCN(C(=O)c3ccco3)CC2)s1
CCC(CC)c1nnc(NC(=O)C2CCN(C(=O)c3ccco3)CC2)s1
1-(furan-2-carbonyl)-N-(5-pentan-3-yl-1,3,4-thiadiazol-2-yl)piperidine-4-carboxamide